242 related articles for article (PubMed ID: 11345378)
1. Response to flecainide infusion predicts long-term success of hybrid pharmacologic and ablation therapy in patients with atrial fibrillation.
Stabile G; De Simone A; Turco P; La Rocca V; Nocerino P; Astarita C; Maresca F; De Matteis C; Di Napoli T; Stabile E; Vitale DF
J Am Coll Cardiol; 2001 May; 37(6):1639-44. PubMed ID: 11345378
[TBL] [Abstract][Full Text] [Related]
2. Long-term results of hybrid therapy in patients with atrial fibrillation who develop atrial flutter during flecainide infusion.
Turco P; De Simone A; La Rocca V; El Jamal B; Nocerino P; Astarita C; De Matteis C; Messina V; Greco L; Rotunno R; Di Napoli T; Vitale DF; Stabile G
Pacing Clin Electrophysiol; 2005 Jan; 28 Suppl 1():S124-7. PubMed ID: 15683478
[TBL] [Abstract][Full Text] [Related]
3. Radiofrequency ablation of atrial flutter due to administration of class IC antiarrhythmic drugs for atrial fibrillation.
Schumacher B; Jung W; Lewalter T; Vahlhaus C; Wolpert C; Lüderitz B
Am J Cardiol; 1999 Mar; 83(5):710-3. PubMed ID: 10080423
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for recurrence of atrial fibrillation in patients undergoing hybrid therapy for antiarrhythmic drug-induced atrial flutter.
Reithmann C; Dorwarth U; Dugas M; Hahnefeld A; Ramamurthy S; Remp T; Steinbeck G; Hoffmann E
Eur Heart J; 2003 Jul; 24(13):1264-72. PubMed ID: 12831821
[TBL] [Abstract][Full Text] [Related]
5. Atrial fibrillation recurrence after drug-induced typical atrial flutter ablation.
Bandini A; Golia P; Pantoli D; Galvani M; Rusticali F
Ital Heart J; 2005 Jul; 6(7):584-90. PubMed ID: 16274021
[TBL] [Abstract][Full Text] [Related]
6. Radiofrequency ablation of "class IC atrial flutter" in patients with resistant atrial fibrillation.
Nabar A; Rodriguez LM; Timmermans C; Smeets JL; Wellens HJ
Am J Cardiol; 1999 Mar; 83(5):785-7, A10. PubMed ID: 10080440
[TBL] [Abstract][Full Text] [Related]
7. Different clinical courses and predictors of atrial fibrillation occurrence after transisthmic ablation in patients with preablation lone atrial flutter, coexistent atrial fibrillation, and drug induced atrial flutter.
Bertaglia E; Bonso A; Zoppo F; Proclemer A; Verlato R; Corò L; Mantovan R; Themistoclakis S; Raviele A; Pascotto P;
Pacing Clin Electrophysiol; 2004 Nov; 27(11):1507-12. PubMed ID: 15546305
[TBL] [Abstract][Full Text] [Related]
8. Incidence and clinical predictors of subsequent atrial fibrillation requiring additional ablation after cavotricuspid isthmus ablation for typical atrial flutter.
De Bortoli A; Shi LB; Ohm OJ; Hoff PI; Schuster P; Solheim E; Chen J
Scand Cardiovasc J; 2017 Jun; 51(3):123-128. PubMed ID: 28335638
[TBL] [Abstract][Full Text] [Related]
9. Catheter ablation of atrial flutter due to amiodarone therapy for paroxysmal atrial fibrillation.
Reithmann C; Hoffmann E; Spitzlberger G; Dorwarth U; Gerth A; Remp T; Steinbeck G
Eur Heart J; 2000 Apr; 21(7):565-72. PubMed ID: 10775011
[TBL] [Abstract][Full Text] [Related]
10. Catheter ablation of inducible atrial flutter, in combination with atrial pacing and antiarrhythmic drugs ("hybrid therapy") improves rhythm control in patients with refractory atrial fibrillation.
Prakash A; Saksena S; Krol RB; Filipecki A; Philip G
J Interv Card Electrophysiol; 2002 Jun; 6(2):165-72. PubMed ID: 11992027
[TBL] [Abstract][Full Text] [Related]
11. Management of atrial flutter.
Kongsgaard E; Aass H
Curr Cardiol Rep; 2000 Jul; 2(4):314-21. PubMed ID: 10953265
[TBL] [Abstract][Full Text] [Related]
12. Effect of right atrial isthmus ablation on the occurrence of atrial fibrillation: observations in four patient groups having type I atrial flutter with or without associated atrial fibrillation.
Nabar A; Rodriguez LM; Timmermans C; van den Dool A; Smeets JL; Wellens HJ
Circulation; 1999 Mar; 99(11):1441-5. PubMed ID: 10086967
[TBL] [Abstract][Full Text] [Related]
13. Long-term efficacy of hybrid pharmacologic and ablation therapy in patients with pilsicainide-induced atrial flutter.
Hirao K; Okishige K; Yamamoto N; Otomo K; Azegami K; Isobe M
Clin Cardiol; 2005 Jul; 28(7):338-42. PubMed ID: 16075827
[TBL] [Abstract][Full Text] [Related]
14. Five-year follow-up after catheter ablation of persistent atrial fibrillation using the stepwise approach and prognostic factors for success.
Schreiber D; Rostock T; Fröhlich M; Sultan A; Servatius H; Hoffmann BA; Lüker J; Berner I; Schäffer B; Wegscheider K; Lezius S; Willems S; Steven D
Circ Arrhythm Electrophysiol; 2015 Apr; 8(2):308-17. PubMed ID: 25744570
[TBL] [Abstract][Full Text] [Related]
15. Class IC antiarrhythmic drug induced atrial flutter: electrocardiographic and electrophysiological findings and their importance for long term outcome after right atrial isthmus ablation.
Nabar A; Rodriguez LM; Timmermans C; van Mechelen R; Wellens HJ
Heart; 2001 Apr; 85(4):424-9. PubMed ID: 11250970
[TBL] [Abstract][Full Text] [Related]
16. Common atrial flutter and atrial fibrillation are not always two stages of the same disease. A long-term follow-up study in patients with atrial flutter treated with cavo-tricuspid isthmus ablation.
Delise P; Sitta N; Corò L; Marras E; Sciarra L; Bocchino M; Berton G
J Cardiovasc Med (Hagerstown); 2006 Nov; 7(11):800-5. PubMed ID: 17060805
[TBL] [Abstract][Full Text] [Related]
17. Conduction block in the inferior vena caval-tricuspid valve isthmus: association with outcome of radiofrequency ablation of type I atrial flutter.
Schwartzman D; Callans DJ; Gottlieb CD; Dillon SM; Movsowitz C; Marchlinski FE
J Am Coll Cardiol; 1996 Nov; 28(6):1519-31. PubMed ID: 8917267
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the safety and efficacy of flecainide versus propafenone in hospital out-patients with symptomatic paroxysmal atrial fibrillation/flutter. The Flecainide AF French Study Group.
Aliot E; Denjoy I
Am J Cardiol; 1996 Jan; 77(3):66A-71A. PubMed ID: 8607394
[TBL] [Abstract][Full Text] [Related]
19. [The effects of the ablation of atrial flutter in patients with and without a clinical history of paroxysmal atrial fibrillation].
De Sisti A; Leclercq JF; Fiorello P; Palamara A; Attuel P
G Ital Cardiol; 1998 Nov; 28(11):1253-60. PubMed ID: 9866803
[TBL] [Abstract][Full Text] [Related]
20. Flecainide-metoprolol combination reduces atrial fibrillation clinical recurrences and improves tolerability at 1-year follow-up in persistent symptomatic atrial fibrillation.
Capucci A; Piangerelli L; Ricciotti J; Gabrielli D; Guerra F
Europace; 2016 Nov; 18(11):1698-1704. PubMed ID: 26893497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
